Phase 2 data in type 2 diabetes showed CagriSema reduced HbA1c by 2.2 percentage points compared to 1.8 with semaglutide alone and 0.9 with cagrilintide alone, while achieving 15.6% weight loss versus 5.1% with semaglutide alone
Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ: Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement
Contact your healthcare provider right away if you experience severe stomach pain, persistent vomiting, or signs of kidney problems like changes in urination
Thakur, K., Tomar, S
After the first three months, she says patients may sometimes stop the supplements for a ten-day period every month
however, the weight loss gains associated with these drugs has resulted in wider use to combat obesity